World's Best Scientists 2026 revealed!
Suzanne Benjannet

Suzanne Benjannet

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
19135
World Ranking
12935
National Ranking
439

Overview

Suzanne Benjannet is affiliated with the University of Montreal in Canada. Their academic career is connected to this institution, where they engage in research and teaching activities.

No specific data on Suzanne Benjannet's recent papers, co-authors, publication venues, or book publications is available at this time. As such, detailed information about their research outputs and collaboration network cannot be provided.

The primary fields of study, subfields, and main research topics for Suzanne Benjannet have not been explicitly listed. Consequently, it is not possible to describe the exact scientific domains or thematic areas this researcher focuses on.

There is no record of awards associated with Suzanne Benjannet, nor are there known citations or honors documented to indicate external recognition in their field.

Current data indicates that Suzanne Benjannet is living. The lack of detailed publication and research topic data limits the scope of profiling their contributions in greater detail.

Best Publications

  • Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.

    Marianne Abifadel;Mathilde Varret;Jean-Pierre Rabès;Delphine Allard

  • Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

    Martin J Vincent;Eric Bergeron;Suzanne Benjannet;Bobbie R Erickson

  • The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation

    Nabil G. Seidah;Suzanne Benjannet;Louise Wickham;Jadwiga Marcinkiewicz

  • NARC-1/PCSK9 and Its Natural Mutants ZYMOGEN CLEAVAGE AND EFFECTS ON THE LOW DENSITY LIPOPROTEIN (LDL) RECEPTOR AND LDL CHOLESTEROL

    Suzanne Benjannet;David Rhainds;Rachid Essalmani;Janice Mayne

  • PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues.

    S Benjannet;N Rondeau;R Day;M Chrétien

  • Cloning and primary sequence of a mouse candidate prohormone convertase PC1 homologous to PC2, Furin, and Kex2: distinct chromosomal localization and messenger RNA distribution in brain and pituitary compared to PC2.

    N. G. Seidah;M. Marcinkiewicz;S. Benjannet;L. Gaspar

  • The Proprotein Convertase PCSK9 Induces the Degradation of Low Density Lipoprotein Receptor (LDLR) and Its Closest Family Members VLDLR and ApoER2

    Steve Poirier;Gaetan Mayer;Suzanne Benjannet;Eric Bergeron

  • Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases

    Nabil G. Seidah;Suzanne Benjannet;Sangeeta Pareek;Michel Chrétien

  • The proprotein convertase (PC) PCSK9 is inactivated by furin and/or PC5/6A: functional consequences of natural mutations and post-translational modifications.

    Suzanne Benjannet;David Rhainds;Josée Hamelin;Nasha Nassoury

  • Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production.

    Suzanne Benjannet;Aram Elagoz;Louise Wickham;Maya Mamarbachi

  • Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases.

    Nabil G. Seidah;Suzanne Benjannet;Sangeeta Pareek;Diane Savaria

  • Mammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localization

    Nabil G. Seidah;Seyed J. Mowla;Josée Hamelin;Aida M. Mamarbachi

  • The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis

    Geraldine Siegfried;Ajoy Basak;James A. Cromlish;Suzanne Benjannet

  • The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR.

    Nasha Nassoury;Daniel A. Blasiole;Angie Tebon Oler;Suzanne Benjannet

  • A new method for measurement of total plasma PCSK9: clinical applications.

    Geneviève Dubuc;Michel Tremblay;Guillaume Paré;Hélène Jacques

  • Comparative biosynthesis, covalent post-translational modifications and efficiency of prosegment cleavage of the prohormone convertases PC1 and PC2: glycosylation, sulphation and identification of the intracellular site of prosegment cleavage of PC1 and PC2.

    S Benjannet;N Rondeau;L Paquet;A Boudreault

  • From β-lipotropin to β-endorphin and 'pro-opio-melanocortin'

    M. Chrétien;S. Benjannet;F. Gossard;C. Gianoulakis

  • Proprotein conversion is determined by a multiplicity of factors including convertase processing, substrate specificity, and intracellular environment. Cell type-specific processing of human prorenin by the convertase PC1.

    S Benjannet;T Reudelhuber;C Mercure;N Rondeau

  • The subtilisin/kexin family of precursor convertases. Emphasis on PC1, PC2/7B2, POMC and the novel enzyme SKI-1.

    Nabil G. Seidah;Suzanne Benjannet;Josée Hamelin;Aida M. Mamarbachi

  • ZYMOGEN CLEAVAGE AND EFFECTS ON THE LOW DENSITY LIPOPROTEIN (LDL) RECEPTOR AND LDL CHOLESTEROL

    Suzanne Benjannet;David Rhainds;Rachid Essalmani;Janice Mayne

Frequent Co-Authors

Nabil G. Seidah
Nabil G. Seidah University of Montreal
Michel Chrétien
Michel Chrétien University of Montreal
Claude Lazure
Claude Lazure University of Montreal
Annik Prat
Annik Prat University of Montreal
Yves Jacob
Yves Jacob Institut Pasteur
Daniel J. Rader
Daniel J. Rader University of Pennsylvania
Etienne Decroly
Etienne Decroly Aix-Marseille University
Catherine Boileau
Catherine Boileau Université Paris Cité
Christina Gianoulakis
Christina Gianoulakis McGill University
Alan D. Attie
Alan D. Attie University of Wisconsin–Madison

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Suzanne Benjannet